Eberconazole (1%-1.3% Eberconazole cream, approximately 1-1.3 g per animal, topical application, twice daily for 6 days) demonstrated significant therapeutic efficacy in the experimentally induced cutaneous candidiasis guinea pig model, with 90% of guinea pigs showing negative culture results from infected skin samples and lesion disappearance, superior to Clotrimazole (HY-10882)[2].
| Animal Model: | Experimentally induced cutaneous candidiasis guinea pig model[2] |
| Dosage: | 1%-1.3% Eberconazole cream, approximately 1-1.3 g per animal |
| Administration: | Topical application, twice daily, for 6 days |
| Result: | Caused 90% of guinea pigs clinically recovered and lesions disappeared. |
